Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism-Reference-Cited by-同舟云学术

Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism

Published:2017-07-03 Issue:1 Volume:8 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Biancur Douglas E.,Paulo Joao A.^ORCID,Małachowska Beata,Quiles Del Rey Maria,Sousa Cristovão M.,Wang Xiaoxu,Sohn Albert S. W.,Chu Gerald C.,Gygi Steven P.,Harper J. Wade,Fendler Wojciech,Mancias Joseph D.,Kimmelman Alec C.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms15965.pdf

Reference53 articles.

1. Ying, H. et al. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 30, 355–385 (2016).

2. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2016. CA. Cancer J. Clin. 66, 7–30 (2016).

3. Almoguera, C. et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53, 549–554 (1988).

4. Waddell, N. et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 518, 495–501 (2015).

5. Bailey, P. et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature 531, 47–52 (2016).

Cited by 243 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting aberrant amino acid metabolism for pancreatic cancer therapy: Opportunities for nanoparticles;Chemical Engineering Journal;2024-10

2. CETZOLE Analogs as Potent Ferroptosis Inducers and Their Target Identification Using Covalent/Affinity Probes;Journal of Medicinal Chemistry;2024-09-12

3. A ferroptosis amplifier based on triple-enhanced lipid peroxides accumulation strategy for effective pancreatic cancer therapy;Biomaterials;2024-09

4. Targeting amino acid-metabolizing enzymes for cancer immunotherapy;Frontiers in Immunology;2024-08-14

5. Targeting cellular adaptive responses to glutaminolysis perturbation for cancer therapy;Molecules and Cells;2024-08